• The global Non-Invasive Drug Delivery Device market was valued at US$ 1.92 billion in 2023 and is projected to reach US$ 3.18 billion by 2030, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
• Non-Invasive Drug Delivery refers to the different administration forms of various therapeutic drugs that people use in the process of preventing and treating diseases without invasion.
• Non-Invasive Drug Delivery Device Market aims to provide a comprehensive presentation of the global market for Non-Invasive Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Drug Delivery Device. Non-Invasive Drug Delivery Device Market contains market size and forecasts of Non-Invasive Drug Delivery Device in global, including the following market information:
Email: help@24marketreports.com Call: +1(646)-781-7170 (Int'l)
Liquid-Based Needle-Free Injector
Powder-Based Needle-Free Injector
• Novartis AG
• Inovio Pharmaceuticals, Inc.
• Medtronic Plc.
• Tandem Diabetes Care, Inc.
• Teva Pharmaceutical Industries Ltd.
